706 related articles for article (PubMed ID: 10742381)
21. [Umbilical cord blood as a source of stem cells].
Bojanić I; Golubić Cepulić B
Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834
[TBL] [Abstract][Full Text] [Related]
22. Repeated hematopoietic stem and progenitor cell mobilization without depletion of the bone marrow stem and progenitor cell pool in mice after repeated administration of recombinant murine G-CSF.
de Kruijf EJ; van Pel M; Hagoort H; Kruysdijk D; Molineux G; Willemze R; Fibbe WE
Hum Immunol; 2007 May; 68(5):368-74. PubMed ID: 17462504
[TBL] [Abstract][Full Text] [Related]
23. Engraftment of W/c-kit mutant mice is determined by stem cell competition, not by increased marrow 'space'.
Fleishman RA
Exp Hematol; 1996 Feb; 24(2):209-13. PubMed ID: 8641343
[TBL] [Abstract][Full Text] [Related]
24. Human hematopoietic progenitor in bone marrow and peripheral blood.
Messner HA
Stem Cells; 1998; 16 Suppl 1():93-6. PubMed ID: 11012151
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity of Ly5 (CD45)-antigens hampers long-term engraftment following minimal conditioning in a murine bone marrow transplantation model.
van Os R; Sheridan TM; Robinson S; Drukteinis D; Ferrara JL; Mauch PM
Stem Cells; 2001; 19(1):80-7. PubMed ID: 11209093
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of TLR2 expression on G-CSF-mobilized peripheral blood stem cells is responsible for their rapid engraftment after allogeneic hematopoietic stem cell transplantation.
Joo YD; Lee WS; Won HJ; Lee SM; Choi JH; Lee SM; Han KH; Park SG; Choi IW; Seo SK
Cytokine; 2011 Apr; 54(1):36-42. PubMed ID: 21239180
[TBL] [Abstract][Full Text] [Related]
27. Relevance of myeloablative conditioning in the engraftment of limiting numbers of normal and genetically marked lympho-hematopoietic stem cells.
Varas F; Bernad A; Almendral JM; Bueren JA
Bone Marrow Transplant; 1996 Nov; 18(5):981-9. PubMed ID: 8932855
[TBL] [Abstract][Full Text] [Related]
28. Ex vivo culture rescues hematopoietic stem cells with long-term repopulating capacity following harvest from lethally irradiated mice.
Chute JP; Fung J; Muramoto G; Erwin R
Exp Hematol; 2004 Mar; 32(3):308-17. PubMed ID: 15003317
[TBL] [Abstract][Full Text] [Related]
29. A murine model of antimetabolite-based, submyeloablative conditioning for bone marrow transplantation: biologic insights and potential applications.
Goebel WS; Pech NK; Meyers JL; Srour EF; Yoder MC; Dinauer MC
Exp Hematol; 2004 Dec; 32(12):1255-64. PubMed ID: 15588950
[TBL] [Abstract][Full Text] [Related]
30. Improved hematopoietic stem cell engraftment following ex vivo expansion of murine marrow cells with SCF and Flt3L.
Diehl A; Stoelting S; Nadrowitz R; Wagner T; Peters SO
Cytotherapy; 2007; 9(6):532-8. PubMed ID: 17882717
[TBL] [Abstract][Full Text] [Related]
31. Soluble c-kit receptor mobilizes hematopoietic stem cells to peripheral blood in mice.
Nakamura Y; Tajima F; Ishiga K; Yamazaki H; Oshimura M; Shiota G; Murawaki Y
Exp Hematol; 2004 Apr; 32(4):390-6. PubMed ID: 15050750
[TBL] [Abstract][Full Text] [Related]
32. Stem cell factor improves the repopulating ability of primitive hematopoietic stem cells after sublethal irradiation (and, to a lesser extent) after bone marrow transplantation in mice.
Gardner RV; Oliver P; Astle CM
Stem Cells; 1998; 16(2):112-9. PubMed ID: 9554035
[TBL] [Abstract][Full Text] [Related]
33. Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency.
Lanfranchi A; Verardi R; Tettoni K; Neva A; Mazzolari E; Pennacchio M; Pasic S; Ugazio AG; Albertini A; Porta F
Haematologica; 2000 Nov; 85(11 Suppl):41-6. PubMed ID: 11268323
[TBL] [Abstract][Full Text] [Related]
34. Fas ligand enhances hematopoietic cell engraftment through abrogation of alloimmune responses and nonimmunogenic interactions.
Pearl-Yafe M; Yolcu ES; Stein J; Kaplan O; Yaniv I; Shirwan H; Askenasy N
Stem Cells; 2007 Jun; 25(6):1448-55. PubMed ID: 17363551
[TBL] [Abstract][Full Text] [Related]
35. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
36. Determinants of skeletal muscle contributions from circulating cells, bone marrow cells, and hematopoietic stem cells.
Sherwood RI; Christensen JL; Weissman IL; Wagers AJ
Stem Cells; 2004; 22(7):1292-304. PubMed ID: 15579647
[TBL] [Abstract][Full Text] [Related]
37. Murine marrow cellularity and the concept of stem cell competition: geographic and quantitative determinants in stem cell biology.
Colvin GA; Lambert JF; Abedi M; Hsieh CC; Carlson JE; Stewart FM; Quesenberry PJ
Leukemia; 2004 Mar; 18(3):575-83. PubMed ID: 14749701
[TBL] [Abstract][Full Text] [Related]
38. Peripheral blood stem cell mobilization: the CXCR2 ligand GRObeta rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties.
Pelus LM; Fukuda S
Exp Hematol; 2006 Aug; 34(8):1010-20. PubMed ID: 16863907
[TBL] [Abstract][Full Text] [Related]
39. Host natural suppressor activity regulates hemopoietic engraftment kinetics in antibody-conditioned recipient mice.
Sadelain MW; Green DR; Wegmann TG
J Immunol; 1990 Mar; 144(5):1729-36. PubMed ID: 1968488
[TBL] [Abstract][Full Text] [Related]
40. Transplantation of chromosomally marked syngeneic marrow cells into mice not subjected to hematopoietic stem cell depletion.
Saxe DF; Boggs SS; Boggs DR
Exp Hematol; 1984 May; 12(4):277-83. PubMed ID: 6370711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
